• Morphotek inks license deal with BlissBio biospectrumasia
    April 11, 2018
    BlissBio has an exclusivity option to expand the territory beyond China to the global market and to develop therapeutic ADCs to two additional undisclosed oncology targets.
  • Morphotek Launches ADC Services Business contractpharma
    April 05, 2017
    Aligns antibody engineering and clinical development assets into a client-focused ADC business
PharmaSources Customer Service